Reaktion #722820

ord-b33c2eb908984462bba04a4ce2e61113

Reaktionsgleichung

O.On1nnc2ccccc21
1-hydroxybenzotriazole monohydrate
CCN=C=NCCCN(C)C.Cl
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
CC[C@H](N)c1ccccc1
(S)-(−)-1-phenylpropylamine
CCCC[C@H](NC(=O)OC(C)(C)C)[C@H](O)C(=O)O
3(S)-(tert-butoxyformamido)-2(S)-hydroxyheptanoic acid
CCCC[C@H](NC(=O)OC(C)(C)C)[C@H](O)C(=O)N[C@@H](CC)c1ccccc1
3(S)-(tert-butoxyformamido)-2(S)-hydroxy-N-(1(S)-phenylpropyl)heptanamide
Ausbeute 75.7%

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Waschenwashed in sequence with 5% citric acid solution, saturated sodium bicarbonate solution and saturated brine
  2. 2
    TrocknenThe organic phase was dried over anhydrous magnesium sulphate
  3. 3
    Sonstigethe solvent was evaporated

Vorschrift

229 mg of 1-hydroxybenzotriazole monohydrate, 287 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 148 mg of (S)-(−)-1-phenylpropylamine were added in sequence to a solution of 260 mg of 3(S)-(tert-butoxyformamido)-2(S)-hydroxyheptanoic acid in 10 ml of dichloromethane. The mixture was stirred at room temperature for 3 hours, then diluted with dichloromethane and washed in sequence with 5% citric acid solution, saturated sodium bicarbonate solution and saturated brine. The organic phase was dried over anhydrous magnesium sulphate and the solvent was evaporated to give 285 mg of 3(S)-(tert-butoxyformamido)-2(S)-hydroxy-N-(1(S)-phenylpropyl)heptanamide, MS: m/e 379.1 [M+H]+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US06187905B1uspto-grants-2001_02